arcellx

arcellx

NASDAQ:ACLX

Chart

Detailed Quote

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
Featured Articles and Interviews
Scientists examining a sample under a microscope in a lab setting.

Gilead to Acquire Arcellx in US$7.8 Billion Bet on Cancer Therapy

Hand holding glowing DNA strands with molecular structures.

How to Invest in Gene Stocks and ETFs

Press Releases

Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma

Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition

The Conversation (0)